Known targets — ChEMBL curated mechanism
S1PR1S1PR2S1PR3S1PR4S1PR5rplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RECQL | P46063 | 2/20 | 0.72 |
| ▸ | GLA | P06280 | 1/20 | 0.72 |
| ▸ | HPGD | P15428 | 1/20 | 0.72 |
| ▸ | TSHR | P16473 | 1/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.72 |
| ▸ | BLM | P54132 | 1/20 | 0.72 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.54 |
| ▸ | APAF1 | O14727 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.50 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | CA1 | P00915 | 9/20 | 0.48 |
| ▸ | CA2 | P00918 | 9/20 | 0.48 |
| ▸ | CA9 | Q16790 | 8/20 | 0.48 |
| ▸ | CA12 | O43570 | 3/20 | 0.48 |
| ▸ | CA7 | P43166 | 3/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.48 |
| ▸ | CA3 | P07451 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA6 | P23280 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11070921 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL28963387 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| Cetrimonium SCHEMBL9514179 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4412977 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL1639772 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| Cetrimonium SCHEMBL31151344 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| SCHEMBL4462066 | 1.00 | RECQL (0.72) | RECQLGLAHPGDTSHRMAPK1 | |
| Cetrimonium SCHEMBL9320451 | 0.98 | RECQL (0.70) | RECQLGLAHPGDTSHRMAPK1 | |
| Hydrochloric Acid SCHEMBL12096944 | 0.97 | RECQL (0.73) | RECQLGLAHPGDTSHRMAPK1 | |
| Cetrimonium SCHEMBL2596194 | 0.97 | RECQL (0.73) | RECQLGLAHPGDTSHRMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7544807-B2 | Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting | MERCK PATENT GMBH (DE) | 2009-06-09 | — | — | US | disclosed |
| US-20080033178-A1 | Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting | MERCK PATENT GMBH (DE) | 2008-02-07 | — | — | US | disclosed |
| US-7252791-B2 | sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers | MERCK PATENT GMBH (DE) | 2007-08-07 | — | — | US | disclosed |
| US-20040262578-A1 | sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers | MERCK PATENT GMBH (DE) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040262578-A1 | sulfonic acids and salts such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers | RPS4Y1, HSPA4, RPS4X | RECQL 2836/4885GLA 4606/4885HPGD 3651/4885 |
| US-20080033178-A1 | Alkyl sulfates such as 1-ethyl-3-methylimidazolium butyl sulfate, used as solvents or solvent adjuvants in chemical reactions, extraction agents or heat carriers in heat exchangers; low melting | MRPS34, HSPA4, SLC43A1 | RECQL 2266/4885GLA 4143/4885HPGD 3931/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.